Transfusion support in hematopoietic stem cell transplantation
Dong-Wook JEKARL; Jae-Kwon KIM; Jay-Ho HAN; Howon LEE; Jaeeun YOO; Jihyang LIM; Yonggoo KIM.
Blood Research
; : 1-7, 2023.
Artículo
en Inglés
| WPRIM | ID: wpr-999719
Transfusion support for hematopoietic stem cell transplantation (HSCT) is an essential part of supportive care, and compatible blood should be transfused into recipients. As leukocyte antigen (HLA) matching is considered first and as the blood group does not impede HSCT, major, minor, bidirectional, and RhD incompatibilities occur that might hinder transfusion and cause adverse events. Leukocyte reduction in blood products is frequently used, and irradiation should be performed for blood products, except for plasma. To mitigate incompatibility and adverse events, local transfusion guidelines, hospital transfusion committees, and patient management should be considered.
Biblioteca responsable:
WPRO
Texto completo
Documentos relacionados